The field of immunotherapy for melanoma is rapidly evolving. Recent developments, such as key data published or presented, have provided insights into the ever-expanding role of immune checkpoint inhibitors (ICIs) in the management of both early and advanced disease. Join this engaging case-based review of current treatments and see where emerging treatments are heading.
- Provider:Paradigm Medical Communications, LLC
- Activity Link: https://ce.paradigmmc.com/a/ROUFUL
- Start Date: 2024-08-22 05:00:00
- End Date: 2024-08-22 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: Source: Merck (Any division) - Amount: 82300.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest